Press releases
- Aurora Improves Offerings in Australia with New Range of Premium Dried Flower Products
- Aurora Cannabis Commends Germany's Landmark Legalization Achievement
- Aurora Cannabis Achieves Australia's TGA GMP Certification, Setting Global Standard for Quality and Compliance
- Aurora Introduces Medical Cannabis Pastilles for Patient Relief in Australia
- Aurora Completes Final Repayment of Convertible Senior Notes Representing ~$465 Million in Total Repayments Since 2021; Cannabis Operations Are Now Debt Free[1]
- Aurora Partners with Script Assist to Provide Better Access to UK Medical Cannabis
- Aurora Cannabis Announces CFO Transition and Completion of Previously Announced Share Consolidation
- Aurora Cannabis Announces Fiscal 2024 Third Quarter Results; Generates Record Adjusted EBITDA of $4.3 Million
- Aurora Cannabis Acquires MedReleaf Australia
More ▼
Key statistics
On Friday, Aurora Cannabis Inc (21P:FRA) closed at 6.20, -42.51% below its 52-week high of 10.79, set on Sep 12, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 6.46 |
---|---|
High | 6.67 |
Low | 6.19 |
Bid | 6.24 |
Offer | 6.29 |
Previous close | 6.20 |
Average volume | 226.94k |
---|---|
Shares outstanding | 54.54m |
Free float | 54.54m |
P/E (TTM) | -- |
Market cap | 501.76m CAD |
EPS (TTM) | -3.39 CAD |
Data delayed at least 15 minutes, as of May 03 2024 20:23 BST.
More ▼